This scientific poster explores ex vivo human skin as a model of general inflammation, highlighting its use for evaluating inflammatory responses across Th1, Th2, Th17, and LPS pathways. The data demonstrates how human skin models can support pathway differentiation, inhibitor assessment, and more predictive preclinical decision-making in inflammatory drug development.
